Dive In: Allianz Re’s Kenrick Law says diversity “a necessity”
September 23 2020 by Andrew Tjaardstra and Yvonne Lau
-
QBE’s Gordon Wong joins MSIG Hong Kong as senior vice president
- November 15
In his new role, Wong will drive all intermediate business and oversee the growth of broker, agency and Macau channels.
-
Hannover Re Malaysia to axe about 30 roles in data and technology, special project teams
- November 15
The reinsurer told IAN that it has decided that a "very limited number of non-underwriting jobs are no longer required" and is working with the affected colleagues on all possible alternatives.
-
Market consolidation crucial for APAC’s maturing economies: AM Best’s Carter
- November 14
Regulators are looking at capital reforms to drive consolidation, but the markets have yet to see the impact, says the rating agency’s APAC managing director.
-
McLarens eyes acquisitions in non-claims technical advisory services
- November 12
The global adjuster identifies forensic engineering, quantity surviving and forensic accounting as potential areas interest for deals.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
